Ypsomed To Invest $249M, Create 62 New Jobs In Holly Springs

Ypsomed, a Swiss developer of injection and infusion systems, is making a significant move into North Carolina’s life sciences landscape with a $249 million investment in Holly Springs. This expansion will establish a state-of-the-art manufacturing facility focused on producing auto-injectors, a growing segment in drug delivery technology. The project is expected to create 62 new jobs and further solidify Holly Springs as a hub for biomanufacturing innovation. The decision was influenced by the region’s skilled workforce, infrastructure, and proximity to major biotech players. With construction slated to begin in 2025, the facility will support both global demand and local economic growth.

For professionals tracking industry expansion, workforce development, or advanced drug delivery systems, gain a compelling look at this strategic investment in the U.S. life sciences sector.